Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer

Gynecologic Oncology

Volumn 92, Issue 2, 2004, Pages 705-707

  Geisler, John P ^a,b   Schraith, Daniel F ^a   Manahan, Kelly J ^a   Sorosky, Joel I ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Indiana Gynecologic Oncology   (United States)

Author keywords

Gemcitabine; Necrotizing enterocolitis; Ovarian neoplasm; Peritoneal neoplasm; Vasculitis

Indexed keywords

CARBOPLATIN; CEFEPIME; GEMCITABINE; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ALLERGIC VASCULITIS; AUTOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE COURSE; FEMALE; HUMAN; INTENSIVE CARE UNIT; NECROTIZING ENTEROCOLITIS; OVARY CARCINOMA; PERITONEUM CANCER; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; TREATMENT FAILURE;

EID: 0842267348     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.10.050     Document Type: Article

References (14)

1. Stellato T.A., Shenk R.R. Gastrointestinal emergencies in the oncology patient. Semin. Oncol. 16:1989;521-531.
2. Petruzzelli G.J., Johnson J.T., deVries E.J. Neutropenic enterocolitis: a new complication of head and neck cancer chemotherapy. Arch. Otolaryngol. Head Neck Surg. 116:1990;209-211.
3. Pestalozzi B.C., Sotos G.A., Choyke P.L., Fisherman J.S., Cowan K.H., O'Shaughnessy J.A. Typhlitis resulting from treatment with Taxol and doxorubicin in patients with metastatic breast cancer. Cancer. 71:1993;1797-1800.
4. Lund B., Hansen O.P., Neijt J.P., Theilade K., Hansen M. Phase II study of gemcitabine in previously treated ovarian cancer patients. Anti-Cancer Drugs. 6s:1995;61-62.
5. Christman K., Kelsen D., Saltz L., Tarassoff P.G. Phase II trial of gemcitabine in patients with advanced gastric cancer. Cancer. 73:1994;5-7.
6. Banach M.J., Williams G.A. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy. Arch. Ophthalmol. 118:2000;726.
7. Voorburg A.M., van Beek F.T., Slee P.H., Seldenrijk C.A., Schramel F.M. Vasculitis due to gemcitabine. Lung Cancer. 36:2002;203-205.
8. Safran H., Dipetrillo T., Iannitti D., Quirk D., Akerman P., Cruff D.et al. Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a phase I trial. Int. J. Radiat. Oncol. Biol. 54:2002;137-141.
9. D'Agostino G., Amant F., Berteloot P., Scambia G., Vergote I. Phase II study of gemcitabine in recurrent platinum- and paclitaxel-resistant ovarian cancer. Gynecol. Oncol. 88:2003;266-269.
10. Garcia A.A., Bookman M.A., Rodriguez-Rodriguez L., Mutch D.G., Look K.Y. Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: a Gynecologic Oncology Group study. Invest. New Drugs. 20:2002;383-387.
11. Nagourney R.A., Brewer C.A., Radecki S., Kidder W.A., Sommers B.L., Evans S.S.et al. Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. Gynecol. Oncol. 88:2003;35-39.
12. Rose P.G., Mossbruger K., Fusco N., Smrekar M., Eaton S., Rodriguez M. Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum- and multidrug-resistant ovarian and peritoneal carcinoma. Gynecol. Oncol. 88:2003;17-21.
13. Calabrese L.H., Duna G.F. Drug-induced vasculitis. Curr. Opin. Rheumatol. 8:1996;34-40.
14. Pouwels M.J.M., Donnelly J.P., Raemaekers J.M.M., Verweij P.E., de Pauw B.E. Clostridium septicum sepsis and netropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia. Ann. Hematol. 74:1997;143-147.